Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LEVADE T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cuvillier, O; Nava, VE; Murthy, SK; Edsall, LC; Levade, T; Milstien, S; Spiegel, S
      Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells

      CELL DEATH AND DIFFERENTIATION
    2. Bezombes, C; Segui, B; Cuvillier, O; Bruno, AP; Uro-Coste, E; Gouaze, V; Andrieu-Abadie, N; Carpentier, S; Laurent, G; Salvayre, R; Jaffrezou, JP; Levade, T
      Lysosomal sphingomyelinase is not solicited for apoptosis signaling

      FASEB JOURNAL
    3. Jafrezou, JP; Bruno, AP; Moisand, A; Levade, T; Laurent, G
      Activation of a nuclear sphingomyelinase in radiation-induced apoptosis

      FASEB JOURNAL
    4. Andrieu-Abadie, N; Gouaze, V; Salvayre, R; Levade, T
      Ceramide in apoptosis signaling: Relationship with oxidative stress

      FREE RADICAL BIOLOGY AND MEDICINE
    5. Paschke, E; Milos, I; Kreitner-Erlacher, H; Hoefler, G; Hoeltzenbein, M; Kleijer, W; Levade, T; Michelakakis, H; Radeva, B
      Mutation analyses in 17 patients with deficiency in acid beta-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B

      HUMAN GENETICS
    6. Veldman, RJ; Maestre, N; Aduib, OM; Medin, JA; Salvayre, R; Levade, T
      A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling

      BIOCHEMICAL JOURNAL
    7. Qin, GJ; Takenaka, T; Telsch, K; Kelley, L; Howard, T; Levade, T; Deans, R; Howard, BH; Malech, HL; Brady, RO; Medin, JA
      Preselective gene therapy for Fabry disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Gouaze, V; Mirault, ME; Carpentier, S; Salvayre, R; Levade, T; Andrieu-Abadie, N
      Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells

      MOLECULAR PHARMACOLOGY
    9. Sanchez, C; Rueda, D; Segui, B; Galve-Roperh, I; Levade, T; Guzman, M
      The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan

      MOLECULAR PHARMACOLOGY
    10. Segui, B; Cuvillier, O; Adam-Klages, S; Garcia, V; Malagarie-Cazenave, S; Leveque, S; Caspar-Bauguil, S; Coudert, J; Salvayre, R; Kronke, M; Levade, T
      Involvement of FAN in TNF-induced apoptosis

      JOURNAL OF CLINICAL INVESTIGATION
    11. Morjani, H; Aouali, N; Belhoussine, R; Veldman, RJ; Levade, T; Manfait, M
      Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets

      INTERNATIONAL JOURNAL OF CANCER
    12. Levade, T; Auge, N; Veldman, RJ; Cuvillier, O; Negre-Salvayre, A; Salvayre, R
      Sphingolipid mediators in cardiovascular cell biology and pathology

      CIRCULATION RESEARCH
    13. Cuvillier, O; Levade, T
      Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria

      BLOOD
    14. Maziere, C; Conte, MA; Leborgne, L; Levade, T; Hornebeck, W; Santus, R; Maziere, JC
      UVA radiation stimulates ceramide production: Relationship to oxidative stress and potential role in ERK, JNK, and p38 activation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    15. Segui, B; Bezombes, C; Uro-Coste, E; Medin, JA; Andrieu-Abadie, N; Auge, N; Brouchet, A; Laurent, G; Salvayre, R; Jaffrezou, JP; Levade, T
      Stress-induced apoptosis is not mediated by endolysosomal ceramide

      FASEB JOURNAL
    16. Plo, I; Lautier, D; Levade, T; Sekouri, H; Jaffrezou, JP; Laurent, G; Bettaieb, A
      Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappa B activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells

      BIOCHEMICAL JOURNAL
    17. Delisle, MB; Uro-Coste, E; Salvayre, R; Levade, T
      Lysosomal disorders - Diagnostic role of extra-cerebral biopsy

      ANNALES DE PATHOLOGIE
    18. Auge, N; Negre-Salvayre, A; Salvayre, R; Levade, T
      Sphingomyelin metabolites in vascular cell signaling and atherogenesis

      PROGRESS IN LIPID RESEARCH
    19. Davaille, J; Gallois, C; Habib, A; Li, LY; Mallat, A; Tao, JC; Levade, T; Lotersztajn, S
      Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts - A cyclooxygenase-2 mediated pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Levade, T; Jaffrezou, JP
      Signalling sphingomyelinases: which, where, how and why?

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    21. Medin, JA; Takenaka, T; Carpentier, S; Garcia, V; Basile, JP; Segui, B; Andrieu-Abadie, N; Auge, N; Salvayre, R; Levade, T
      Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells

      HUMAN GENE THERAPY
    22. Andrieu-Abadie, N; Jaffrezou, JP; Hatem, S; Laurent, G; Levade, T; Mercadier, JJ
      L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation

      FASEB JOURNAL
    23. Andrieu-Abadie, N; Levade, T; Laurent, G; Hatem, S; Mercadier, JJ
      Doxorubicine alters cardiac myocyte through the ceramide pathway?

      M S-MEDECINE SCIENCES
    24. Gomez-Brouchet, A; Cintas, P; Lagier, E; Voisin, T; Delisie, MB; Fabre, N; Gerand, G; Salvayre, R; Levade, T
      Adult Sandhoff disease presenting with chronic diarrhoea

      JOURNAL OF INHERITED METABOLIC DISEASE
    25. Bettaieb, A; Plo, I; Mansat-De Mas, V; Quillet-Mary, A; Levade, T; Laurent, G; Jaffrezou, JP
      Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: Implication in drug-induced ceramide generation and apoptosis

      MOLECULAR PHARMACOLOGY
    26. Segui, B; Andrieu-Abadie, N; Adam-Klages, S; Meilhac, O; Kreder, D; Garcia, V; Bruno, AP; Jaffrezou, JP; Salvayre, R; Kronke, M; Levade, T
      CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    27. Auge, N; Nikolova-Karakashian, M; Carpentier, S; Parthasarathy, S; Negre-Salvayre, A; Salvayre, R; Merrill, AH; Levade, T
      Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized lowdensity lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    28. Levade, T; Andrieu-Abadie, N; Segui, B; Auge, N; Chatelut, M; Jaffrezou, JP; Salvayre, R
      Sphingomyelin-degrading pathways in human cells - Role in cell signalling

      CHEMISTRY AND PHYSICS OF LIPIDS
    29. Delpy, E; Hatem, SN; Andrieu, N; de Vaumas, C; Henaff, M; Rucker-Martin, C; Jaffrezou, JP; Laurent, G; Levade, T; Mercadier, JJ
      Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes

      CARDIOVASCULAR RESEARCH
    30. BRUNO AP; LAURENT G; AVERBECK D; DEMUR C; BONNET J; BETTAIEB A; LEVADE T; JAFFREZOU JP
      LACK OF CERAMIDE GENERATION IN TF-1 HUMAN MYELOID LEUKEMIC-CELLS RESISTANT TO IONIZING-RADIATION

      Cell death and differentiation
    31. REDONNETVERNHET I; CHATELUT M; SALVAYRE R; LEVADE T
      A NOVEL LYSOSOMAL ACID LIPASE GENE MUTATION IN A PATIENT WITH CHOLESTERYL ESTER STORAGE DISEASE

      Human mutation
    32. REDONNETVERNHET I; CHATELUT M; BUSCAIL L; MAHURAN DJ; SALVAYRE R; LEVADE T
      A619-]G SUBSTITUTION IN THE HEXB GENE IS NOT A DELETERIOUS MUTATION, BUT A FREQUENT POLYMORPHISM

      Human mutation
    33. JAFFREZOU JP; BETTAIEB A; LEVADE T; LAURENT G
      ANTITUMOR AGENT-INDUCED APOPTOSIS IN MYELOID-LEUKEMIA CELLS - A CONTROLLED SUICIDE

      Leukemia & lymphoma
    34. JAFFREZOU JP; MAESTRE N; DEMASMANSAT V; BEZOMBES C; LEVADE T; LAURENT G
      POSITIVE FEEDBACK-CONTROL OF NEUTRAL SPHINGOMYELINASE ACTIVITY BY CERAMIDE

      The FASEB journal
    35. BEZOMBES C; MAESTRE N; LAURENT G; LEVADE T; BETTAIEB A; JAFFREZOU JP
      RESTORATION OF TNF-ALPHA-INDUCED CERAMIDE GENERATION AND APOPTOSIS INRESISTANT HUMAN LEUKEMIA KG1A CELLS BY THE P-GLYCOPROTEIN BLOCKER PSC833

      The FASEB journal
    36. BAUMGARTNER MR; POLLTHE BT; VERHOEVEN NM; JAKOBS C; ESPEEL M; ROELS F; RABIER D; LEVADE T; ROLLAND MO; MARTINEZ M; WANDERS RJA; SAUDUBRAY JM
      CLINICAL APPROACH TO INHERITED PEROXISOMAL DISORDERS - A SERIES OF 27PATIENTS

      Annals of neurology
    37. Chatelut, M; Caspar-Bauguil, S; Tkaczuk, J; Alibaud, L; Pieraggi, MT; Roudani, S; Vacaresse, N; Feunteun, J; Laharrague, P; Duchayne, E; Demur, C; Vincent, MC; Thiers, JC; Salvayre, R; Levade, T
      Establishment and characterization of a human T-lymphocyte cell line immortalized by SV40 and with abnormal expression of TCR/CD3

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    38. ANDRIEUABADIE N; CARPENTIER S; SALVAYRE R; LEVADE T
      THE TUMOR NECROSIS FACTOR-SENSITIVE POOL OF SPHINGOMYELIN IS RESYNTHESIZED IN A DISTINCT COMPARTMENT OF THE PLASMA-MEMBRANE

      Biochemical journal
    39. Levade, T
      X-linked ichthyosis: Development of a new cell model and cholesterol sulfate metabolism

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    40. GALVEROPERH I; SANCHEZ C; SEGUI B; HARO A; DIAZLAVIADA I; LEVADE T
      EVIDENCE FOR THE LACK OF INVOLVEMENT OF SPHINGOMYELIN HYDROLYSIS IN THE TUMOR NECROSIS FACTOR-INDUCED SECRETION OF NERVE GROWTH-FACTOR IN PRIMARY ASTROCYTE CULTURES

      Journal of neurochemistry
    41. ESCARGUEILBLANC I; ANDRIEUABADIE N; CASPARBAUGUIL S; BROSSMER R; LEVADE T; NEGRESALVAYRE A; SALVAYRE R
      APOPTOSIS AND ACTIVATION OF THE SPHINGOMYELIN-CERAMIDE PATHWAY INDUCED BY OXIDIZED LOW-DENSITY LIPOPROTEINS ARE NOT CAUSALLY RELATED IN ECV-304 ENDOTHELIAL-CELLS

      The Journal of biological chemistry
    42. AUGE N; ESCARGUEILBLANC I; LAJOIEMAZENC I; SUC I; ANDRIEUABADIE N; PIERAGGI MT; CHATELUT M; THIERS JC; JAFFREZOU JP; LAURENT G; LEVADE T; NEGRESALVAYRE A; SALVAYRE R
      POTENTIAL ROLE FOR CERAMIDE IN MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION AND PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS INDUCED BY OXIDIZED LOW-DENSITY-LIPOPROTEIN

      The Journal of biological chemistry
    43. LIU B; ANDRIEUABADIE N; LEVADE T; ZHANG P; OBEID LM; HANNUN YA
      GLUTATHIONE REGULATION OF NEUTRAL SPHINGOMYELINASE IN TUMOR NECROSIS FACTOR-ALPHA-INDUCED CELL-DEATH

      The Journal of biological chemistry
    44. CHATELUT M; LERUTH M; HARZER K; DAGAN A; MARCHESINI S; GATT S; SALVAYRE R; COURTOY P; LEVADE T
      NATURAL CERAMIDE IS UNABLE TO ESCAPE THE LYSOSOME, IN CONTRAST TO A FLUORESCENT ANALOG

      FEBS letters
    45. DELPY E; HATEM SN; ANDRIEUABADIE N; RUCKERMARTIN C; JAFFREZOU JP; LAURENT G; LEVADE T; MERCADIER JJ
      DOXORUBICIN INDUCES CERAMIDE ACCUMULATION AND APOPTOSIS OF ADULT-RAT CARDIAC MYOCYTES IN-VITRO

      Circulation
    46. REDONNETVERNHET I; CHATELUT M; BASILE JP; SALVAYRE R; LEVADE T
      CHOLESTERYL ESTER STORAGE DISEASE - RELATIONSHIP BETWEEN MOLECULAR DEFECTS AND IN-SITU ACTIVITY OF LYSOSOMAL ACID LIPASE

      Biochemical and molecular medicine
    47. MANSAT V; BETTAIEB A; LEVADE T; LAURENT G; JAFFREZOU JP
      SERINE-PROTEASE INHIBITORS BLOCK NEUTRAL SPHINGOMYELINASE ACTIVATION,CERAMIDE GENERATION, AND APOPTOSIS TRIGGERED BY DAUNORUBICIN

      The FASEB journal
    48. FROISSART R; MAIRE I; BONNET V; LEVADE T; BOZON D
      GERMLINE AND SOMATIC MOSAICISM IN A FEMALE CARRIER OF HUNTER DISEASE

      Journal of Medical Genetics
    49. HARZER K; PATON BC; CHRISTOMANOU H; CHATELUT M; LEVADE T; HIRAIWA M; OBRIEN JS
      SAPOSIN (SAP) A AND SAPOSIN-C ACTIVATE THE DEGRADATION OF GALACTOSYLCERAMIDE IN LIVING CELLS

      FEBS letters
    50. CHATELUT M; HARZER K; CHRISTOMANOU H; FEUNTEUN J; PIERAGGI MT; PATON BC; KISHIMOTO Y; OBRIEN JS; BASILE JP; THIERS JC; SALVAYRE R; LEVADE T
      MODEL SV40-TRANSFORMED FIBROBLAST LINES FOR METABOLIC STUDIES OF HUMAN PROSAPOSIN AND ACID CERAMIDASE DEFICIENCIES

      Clinica chimica acta
    51. MANSAT V; LAURENT G; LEVADE T; BETTAIEB A; ZAFFREZOU JP
      THE PROTEIN-KINASE-C ACTIVATORS PHORBOL ESTERS AND PHOSPHATIDYLSERINEINHIBIT NEUTRAL SPHINGOMYELINASE ACTIVATION, CERAMIDE GENERATION, ANDAPOPTOSIS TRIGGERED BY DAUNORUBICIN

      Cancer research
    52. LAURENT G; BETTAIEB A; MANSAT V; LEVADE T; SCHLAIFER D; JAFFREZOU JP
      DRUG-INDUCED DIACYLGLYCEROL PRODUCTION REGULATES INTRACELLULAR CERAMIDE CONCENTRATION, APOPTOSIS AND CYTOTOXICITY

      Blood
    53. REDONNETVERNHET I; MAHURAN DJ; SALVAYRE R; DUBAS F; LEVADE T
      SIGNIFICANCE OF 2 POINT MUTATIONS PRESENT IN EACH HEXB ALLELE OF PATIENTS WITH ADULT G(M2) GANGLIOSIDOSIS (SANDHOFF DISEASE) - HOMOZYGOSITYFOR THE ILE(207)-]VAL SUBSTITUTION IS NOT ASSOCIATED WITH A CLINICAL OR BIOCHEMICAL PHENOTYPE

      Biochimica et biophysica acta. Molecular basis of disease
    54. SCHMITT DA; HATTON JP; EMOND C; CHAPUT D; PARIS H; LEVADE T; CAZENAVE JP; SCHAFFAR L
      THE DISTRIBUTION OF PROTEIN-KINASE-C IN HUMAN-LEUKOCYTES IS ALTERED IN MICROGRAVITY

      The FASEB journal
    55. LEVADE T; JAFFREZOU JP; ANDRIEU N; LAURENT G
      MECHANISMS OF CYTOTOXICITY OF MAJOR ANTIT UMOR AGENTS AND THE SPHINGOMYELIN-CERAMIDE SIGNALING PATHWAY

      MS. Medecine sciences
    56. JAFFREZOU JP; LEVADE T; BETTAIEB A; ANDRIEU N; BEZOMBES C; MAESTRE N; VERMEERSCH S; ROUSSE A; LAURENT G
      DAUNORUBICIN-INDUCED APOPTOSIS - TRIGGERING OF CERAMIDE GENERATION THROUGH SPHINGOMYELIN HYDROLYSIS

      EMBO journal
    57. REDONNETVERNHET I; VANAMSTEL JKP; JANSEN RPM; WEVERS RA; SALVAYRE R; LEVADE T
      UNEVEN X INACTIVATION IN A FEMALE MONOZYGOTIC TWIN PAIR WITH FABRY DISEASE AND DISCORDANT EXPRESSION OF A NOVEL MUTATION IN THE ALPHA-GALACTOSIDASE-A GENE

      Journal of Medical Genetics
    58. LEVADE T; LERUTH M; GRABER D; MOISAND A; VERMEERSCH S; SALVAYRE R; COURTOY PJ
      IN-SITU ASSAY OF ACID SPHINGOMYELINASE AND CERAMIDASE BASED ON LDL-MEDIATED LYSOSOMAL TARGETING OF CERAMIDE-LABELED SPHINGOMYELIN

      Journal of lipid research
    59. AUGE N; ANDRIEU N; NEGRESALVAYRE A; THIERS JC; LEVADE T; SALVAYRE R
      THE SPHINGOMYELIN-CERAMIDE SIGNALING PATHWAY IS INVOLVED IN OXIDIZED LOW-DENSITY LIPOPROTEIN-INDUCED CELL-PROLIFERATION

      The Journal of biological chemistry
    60. ANDRIEU N; SALVAYRE R; LEVADE T
      COMPARATIVE-STUDY OF THE METABOLIC POOLS OF SPHINGOMYELIN AND PHOSPHATIDYLCHOLINE SENSITIVE TO TUMOR-NECROSIS-FACTOR

      European journal of biochemistry
    61. CHATELUT M; FEUNTEUN J; HARZER K; FENSOM AH; BASILE JP; SALVAYRE R; LEVADE T
      A SIMPLE METHOD FOR SCREENING FOR FARBER-DISEASE ON CULTURED SKIN FIBROBLASTS

      Clinica chimica acta
    62. LEVADE T; TEMPESTA MC; MOSER HW; FENSOM AH; HARZER K; MOSER AB; SALVAYRE R
      SULFATIDE AND SPHINGOMYELIN LOADING OF LIVING CELLS AS TOOLS FOR THE STUDY OF CERAMIDE TURNOVER BY LYSOSOMAL CERAMIDASE - IMPLICATIONS FOR THE DIAGNOSIS OF FARBER-DISEASE

      Biochemical and molecular medicine
    63. TEMPESTA MC; SALVAYRE R; BONAFE JL; LEVADE T
      CHOLESTEROL SULFATE IS NOT DEGRADED BUT DOES NOT ACCUMULATE IN EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOID-CELLS FROM PATIENTS WITH X-LINKED ICHTHYOSIS

      Biochimica et biophysica acta. Molecular basis of disease
    64. LEVADE T; ENDERS H; SCHLIEPHACKE M; HARZER K
      FAMILY WITH COMBINED FARBER AND SANDHOFF, ISOLATED SANDHOFF AND ISOLATED FETAL FARBER-DISEASE - POSTNATAL EXCLUSION AND PRENATAL-DIAGNOSIS OF FARBER-DISEASE USING LIPID LOADING TESTS ON INTACT CULTURED-CELLS

      European journal of pediatrics
    65. JAFFREZOU JP; CHEN G; DURAN GE; MULLER C; BORDIER C; LAURENT G; SIKIC BI; LEVADE T
      INHIBITION OF LYSOSOMAL ACID SPHINGOMYELINASE BY AGENTS WHICH REVERSEMULTIDRUG-RESISTANCE

      Biochimica et biophysica acta. Molecular cell research
    66. COPPENS I; BASTIN P; LEVADE T; COURTOY PJ
      ACTIVITY, PHARMACOLOGICAL INHIBITION AND BIOLOGICAL REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE IN TRYPANOSOMA-BRUCEI

      Molecular and biochemical parasitology
    67. LEVADE T; MOSER HW; FENSOM AH; HARZER K; MOSER AB; SALVAYRE R
      NEURODEGENERATIVE COURSE IN CERAMIDASE DEFICIENCY (FARBER-DISEASE) CORRELATES WITH THE RESIDUAL LYSOSOMAL CERAMIDE TURNOVER IN CULTURED LIVING PATIENT CELLS

      Journal of the neurological sciences
    68. ANDRIEU N; SALVAYRE R; JAFFREZOU JP; LEVADE T
      LOW-TEMPERATURES AND HYPERTONICITY DO NOT BLOCK CYTOKINE-INDUCED STIMULATION OF THE SPHINGOMYELIN PATHWAY BUT INHIBIT NUCLEAR FACTOR-KAPPA-B ACTIVATION

      The Journal of biological chemistry
    69. COPPENS I; LEVADE T; COURTOY PJ
      HOST PLASMA LOW-DENSITY-LIPOPROTEIN PARTICLES AS AN ESSENTIAL SOURCE OF LIPIDS FOR THE BLOOD-STREAM FORMS OF TRYPANOSOMA-BRUCEI

      The Journal of biological chemistry
    70. LEVADE T; VIDAL F; VERMEERSCH S; ANDRIEU N; GATT S; SALVAYRE R
      DEGRADATION OF FLUORESCENT AND RADIOLABELED SPHINGOMYELINS IN INTACT-CELLS BY A NONLYSOSOMAL PATHWAY

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    71. LEVADE T; GRABER D; FLURIN V; DELISLE MB; PIERAGGI MT; TESTUT MF; CARRIERE JP; SALVAYRE R
      HUMAN BETA-MANNOSIDASE DEFICIENCY ASSOCIATED WITH PERIPHERAL NEUROPATHY

      Annals of neurology
    72. ANDRIEU N; SALVAYRE R; LEVADE T
      EVIDENCE AGAINST INVOLVEMENT OF THE ACID LYSOSOMAL SPHINGOMYELINASE IN THE TUMOR-NECROSIS-FACTOR-INDUCED AND INTERLEUKIN-1-INDUCED SPHINGOMYELIN CYCLE AND CELL-PROLIFERATION IN HUMAN FIBROBLASTS

      Biochemical journal
    73. TEMPESTA MC; SALVAYRE R; LEVADE T
      FUNCTIONAL COMPARTMENTS OF SULFATIDE METABOLISM IN CULTURED LIVING CELLS - EVIDENCE FOR THE INVOLVEMENT OF A NOVEL SULFATIDE-DEGRADING PATHWAY

      Biochemical journal
    74. GRABER D; SALVAYRE R; LEVADE T
      ACCURATE DIFFERENTIATION OF NEURONOPATHIC AND NONNEURONOPATHIC FORMS OF NIEMANN-PICK DISEASE BY EVALUATION OF THE EFFECTIVE RESIDUAL LYSOSOMAL SPHINGOMYELINASE ACTIVITY IN INTACT-CELLS

      Journal of neurochemistry
    75. JUDGE MR; ATHERTON DJ; SALVAYRE R; HILAIRE N; LEVADE T; JOHNSTON DI; WINCHESTER B; LAKE BD
      NEUTRAL LIPID STORAGE DISEASE - CASE-REPORT AND LIPID STUDIES

      British journal of dermatology
    76. MARGUERY MC; GIORDANO F; PARANT M; SAMALENS G; LEVADE T; SALVAYRE R; MARET A; CALVAS P; BOURROUILLOU G; CANTALA P; BAZEX J
      FABRYS-DISEASE - HETEROZYGOUS FORM OF DIFFERENT EXPRESSION IN 2 MONOZYGOTIC TWIN SISTERS

      Dermatology
    77. LEVADE T; TEMPESTA MC; SALVAYRE R
      THE IN-SITU DEGRADATION OF CERAMIDE, A POTENTIAL LIPID MEDIATOR, IS NOT COMPLETELY IMPAIRED IN FARBER-DISEASE

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 18:38:18